Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition

The consensus guideline development committee of Korean Society of Gynecologic Oncology was reconvened in March 2012. The committee consisted of 36 experts representing 12 university hospitals and professional organizations. The objective of this committee was to develop standardized guidelines for...

Full description

Bibliographic Details
Main Authors: Lee, Jae Kwan, Hong, Jin Hwa, Kang, Sokbom, Kim, Dae-Yeon, Kim, Byoung-Gie, Kim, Sung-Hoon, Kim, Yong-Man, Kim, Jae-Weon, Kim, Jae-Hoon, Kim, Tae-Jin, Kim, Hyun Jung, Kim, Hye Sun, Ryu, Hee-Sug, Song, Jae Yun, Ahn, Hyeong Sik, Yoo, Chong Woo, Yoon, Hye-Kyoung, Lee, Keun-Ho, Lee, Ahwon, Lee, Yonghee, Lee, In Ho, Lee, Jeong-Won, Lee, Taek Sang, Lim, Myong Cheol, Chang, Suk-Joon, Chung, Hyun Hoon, Ju, Woong, Joo, Hee Jae, Hur, Soo-Young, Hong, Sung-Ran, Nam, Joo-Hyun
Format: Online
Language:English
Published: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644696/
Description
Summary:The consensus guideline development committee of Korean Society of Gynecologic Oncology was reconvened in March 2012. The committee consisted of 36 experts representing 12 university hospitals and professional organizations. The objective of this committee was to develop standardized guidelines for cervical cancer screening tests for Korean women and to distribute these guidelines to every clinician, eventually improving the quality of medical care. Since the establishment of the consensus guideline development committee, evidence-based guidelines have either been developed de novo considering specific Korean situations or by adaptation of preexisting consensus guidelines from other countries. Recommendations for cervical cancer screening tests, management of atypical squamous and glandular cells, and management of low-grade and high-grade squamous intraepithelial lesions were developed. Additionally, recommendations for human papillomavirus DNA testing and recommendations for adolescent and pregnant women with abnormal cervical screening test results were also included.